Evidence map›Paper›PMID 42455792›Full record

ArticlePloS one2026

Impact of blood pressure control during pregnancy on long-term maternal cardiovascular health - secondary analysis of a follow-up study 15 years post preeclampsia (PAVA study).

Charlotte Lößner, Anne Loheit, Anna Multhaup, Laura Bäz, Thomas Lehmann, Yvonne Heimann, Ekkehard Schleußner, Marcus Franz, Tanja Groten

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charlotte LößnerDepartment of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Anne LoheitDepartment of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Anna MulthaupDepartment of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Laura BäzDepartment of Internal Medicine I, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Thomas LehmannInstitute of Medical Statistics, Computer Sciences and Documentation, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Yvonne HeimannDepartment of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.ORCID https://orcid.org/0000-0001-7591-2045
Ekkehard SchleußnerDepartment of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Marcus FranzDepartment of Internal Medicine I, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Tanja GrotenDepartment of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.ORCID https://orcid.org/0000-0003-3553-4056

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWithin the PAVA study, we investigated placenta-associated vascular aging in women 15 years after pregnancies complicated by preeclampsia and/or fetal growth restriction. During these pregnancies, blood pressure values >140/90 mmHg were considered to require treatment. Following evidence demonstrating improved pregnancy outcomes with tighter blood pressure control, updated German and international guidelines (International Society for the Study of Hypertension in Pregnancy, ISSHP) now recommend target values below 135/85 mmHg. To evaluate whether blood pressure levels during pregnancy are associated with long-term maternal cardiovascular health, we analyzed the impact of blood pressure control during pregnancy on cardiovascular risk profiles obtained in the PAVA follow-up study.

methodsBetween August 2019 and December 2022, 53 women were examined an average of 15 years after experiencing preeclampsia and/or fetal growth restriction. At the study visit, baseline data were collected, and a comprehensive clinical and functional assessment was performed. This analysis compared 35 women who were hypertensive at follow-up (blood pressure ≥140/90 mmHg and/or antihypertensive medication) with 18 normotensive participants (blood pressure <140/90 mmHg and no antihypertensive medication). Data on blood pressure levels during pregnancy were collected retrospectively from medical records.

resultsBlood pressure data during pregnancy were available for the second trimester in 15 women who later developed hypertension and 4 who remained normotensive, and for the third trimester in 19 and 14 participants, respectively. Data from the first trimester were not available. In group comparisons, systolic blood pressure in the second trimester and diastolic blood pressure in the third trimester were significantly higher in women who were hypertensive at follow-up (155 vs. 140 mmHg, p = 0.027; 96 vs. 87 mmHg, p = 0.026). In adjusted analyses, no statistically significant associations were observed; however, effect estimates suggested a potential association between blood pressure control during pregnancy and lower odds of later arterial hypertension (OR 0.22, 95% CI 0.03-1.53) and concentric remodeling (OR 0.37, 95% CI 0.03-4.29).

conclusionsThese findings suggest that blood pressure levels during pregnancy may be associated with long-term maternal cardiovascular health. However, given the limited sample size and exploratory nature of the analysis, these results should be interpreted with caution and require confirmation in larger prospective studies.

Indexed as

Blood PressurePre-EclampsiaAdultAntihypertensive AgentsFemaleFetal Growth RetardationFollow-Up StudiesHumansMaternal HealthPregnancyAntihypertensive Agents

Identifiers

PMID42455792
PMCPMC13372152

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.